Aristides Capital’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,000
Closed -$583K 302
2024
Q2
$583K Buy
11,000
+6,000
+120% +$318K 0.16% 97
2024
Q1
$410K Buy
+5,000
New +$410K 0.15% 102